SUNNYVALE, Calif., Sept. 26 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at the William Blair & Company Small-Cap Growth Stock Conference on October 3, 2007 at 10:40 a.m. ET at the New York Palace Hotel, New York. John R. Sluis, Cepheid's Chief Financial Officer and Dr. David Persing, Cepheid's Chief Medical and Technology Officer, will provide a corporate overview.
The webcast, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.
Copyright©2007 PR Newswire.
All rights reserved